tailieunhanh - Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells

Docetaxel was used to treat metastatic CRPC patients. However, Doc resistance in prostate cancer (PCa) hinders its clinical application. | Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG